Schoenherr, alongside Willkie Farr & Gallagher, advised premier specialty chemicals company Albemarle Corporation on the sale of its Tribotecc metal sulfides business to Treibacher Industrie AG, an international leading player in the chemistry and metallurgy sectors.
The transaction, which was announced on 5 November 2015 and is expected to close by the end of 2015 following regulatory approvals, includes Tribotecc sites in Vienna and Arnoldstein, Austria and the firm’s proprietary sulfide synthesis process.
New York Stock Exchange-listed Albemarle develops, manufactures and markets technologically advanced and high value added products, including lithium and lithium compounds, bromine and bromine derivatives, catalysts and surface treatment chemistries used in a wide range of applications.
Treibacher Industrie, a privately owned enterprise headquartered in Althofen (Austria), develops and manufactures ferro alloys for the steel and foundry industries, powders for the carbide industry, materials for high performance ceramics as well as fine chemicals and special alloys.
The Schoenherr team advising Albemarle on matters of Austrian law was led by Robert Bachner (partner, Corporate/M&A) and also consisted of Rita Wittmann (counsel, Corporate/M&A), Georgi Tsonchev (attorney, Corporate/M&A), Valentin Menedetter (associate, Corporate/M&A), as well as Bernd Rajal (partner, Regulatory), Michael Woller (attorney, IP), and Mario Johannes Perl (associate, Tax).
Willkie Farr & Gallagher served as lead counsel to Albemarle, while Bank of America Merrill Lynch acted as exclusive financial advisor to Albemarle in connection with this transaction.
Treibacher Industrie was represented by WT Tautschnig Rechtsanwaltsgesellschaft mbH.
